ADTX ADITXT INC Company Mergers 8-K Filing 2025 - Investment Agreement On April 8, 2025, Aditxt, Inc. invested $1.5 million in Evofem Biosciences, acquiring a convertible note of $2.3 million and a warrant for 149.8 million shares, with terms extending to 2028.Get access to all SEC 8-K filings of the ADITXT INC